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ASSESSMENT OF PHYSICAL IMPAIRMENTS IN LEPROSY PATIENTS: A COMPARISON BETWEEN THE 
WORLD HEALTH ORGANIZATION (WHO) DISABILITY GRADE AND THE EYE-HAND-FOOT SCORE
Marcos Túlio RAPOSO(1), Ana Virgínia de Queiroz CAMINHA(1), Jorg HEUKELBACH(2), Miguel Ángel SÁNCHEZ-GONZÁLEZ(3),  
Jovany Luis Alves de MEDEIROS(4) & Maria Ines Battistella NEMES (5)
SUMMARY
This cross-sectional study assessed the grade of physical impairments in 61 individuals with leprosy receiving multidrug therapy 
(MDT) under the Brazilian Unified Health System (SUS), and residing in Campina Grande, Paraíba State, Brazil. Impairments were 
assessed using the disability grade (DG) standardized by the WHO, and the EHF score (Eye-Hand-Foot sum of impairment scores). 
Impairments were detected in 25 (41%) of the subjects. A total of 14 (23%) patients scored DG 1, while 11 (18%) were assigned DG 
2. The EHF score ranged from 1 to 10 points in the group of patients with physical impairments, with a mean score of 3.6 points. The 
majority of individuals with impairments were affected in at least two sites. We conclude that the EHF score showed overlapping 
impairments in the segments examined and may be more appropriate than the DG classification system for describing the degree of 
physical impairment of leprosy patients.
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INTRODUCTION
The data available on physical impairments resulting from leprosy 
varies considerably, although the World Health Organization (WHO) 
estimates indicate that approximately 25% of those with leprosy have 
impairments38. In 2004, an estimated two to three million people were 
disabled by leprosy worldwide37. Trends in prevalence and case detection 
vary from country to country. The prevalence of people with DG 2 
decreases much slower than leprosy incidence and case detection. In 
2020 it is estimated that about one million people will be affected by 
leprosy and living with disability grading 218.
Studies carried out in Brazil have shown that coverage of new cases 
assessed for disability was on average 88% in 200832. The percentage of 
patients presenting grades 1 and 2 of disability were, respectively, 5.7% 
and 18.1% amongst 43,642 new cases of leprosy in 20064. The proportion 
of DG 2 among new cases varies widely between different regions of the 
world and reaches rates from 1% to 21%35.
Other Brazilian studies on the prevalence of impairments at diagnosis 
have reported 7.7% up to 47.8%8,14,15,16,17,21,31, while international research 
in Nigeria22 and Ethiopia25 found rates of 19% and 55%, respectively. 
However, government data from both African countries only report DG 
2. In Larkana-Pakistan, deformities and disabilities were noted in 55% 
of cases27.
In 1960, the WHO recommended the use of a scale to classify physical 
impairments in individuals with leprosy, namely the “disability grading” 
(DG)2,3,41. Working versions of the scale3 were later proposed39,40 and the 
version in use today was recommended by the WHO in 199738. Another 
study recommends that the “WHO Disability Grading” (DG) be renamed 
as the “WHO Impairment Grading” (IG) to address the new perspective 
that the International Classification of Functioning, Disability and Health 
(ICF) suggested20. Under this scale, grades are attributed to each eye, hand 
and foot, where the highest value attributed to these points represents the 
“maximum disability grade” of the individual and is used as an indicator 
of the severity of impairment39. The scale currently adopted by the WHO 
is simplified into three grades3,37 (DG 0 - no disability caused by leprosy 
in eyes, hands and feet. DG 1 - Eye problem caused by leprosy, but vision 
is not severely affected (equals 6/60 or better; fingers can be counted 
at six meters apart); loss of sensibility in hands or feet (not feeling 2g 
mononofil). DG 2 - Eyes: lagophthalmos and/or ectropion; trichiasis; 
visual impairment (fingers not counted at 6m). Hands and feet: with 
visible damage i.e. claw hands, foot drop, reabsorption of fingers or toes, 
wounds)38. Today, the DG is employed as an epidemiological indicator 
to assess leprosy programmes, determine early/late diagnosis33,36 and 
monitor patient follow-up in the health care centre over the course of 
treatment4,36.
The vast majority of impairments occur due to failures of the leprosy 
programmes in terms of rapid diagnosis and treatment. Since most 
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impairments only develop late in the course of the disease9, presence of 
DG 2 at diagnosis indicates late diagnosis28.
In 1971, a method was proposed to evaluate three different types 
of Disability Index to describe physical disabilities at the time of the 
diagnosis. This method had considered disability grade index achieved 
from the arithmetic mean of the added values of the different disability 
grades1. It is important to note that the WHO disability grade was 
considered the best method for evaluating physical disabilities at the 
time of the diagnosis if compared to the absolute disabilities frequency 
and disability grade29.
An alternative scale called the Hand-Foot impairment score (HF 
impairment score)12, was proposed in 1994 and employs the sum of 
impairment grades in hands and feet to monitor physical impairments 
in patients during the course of multidrug therapy (MDT) and over a 
five-year period after cure.
Previous studies6,10,19,24,30 have also employed the Eye-Hand-Foot 
impairment score (EHF score), which uses the sum of impairment grades 
assigned individually to each segment examined and encompasses eyes as 
well as hands and feet, yielding a total score which ranges from 0 (zero) 
to a maximum of 12 points. The EHF tool is an indicator of severity 
and development of impairment and allows changes in the stages of 
impairment to be monitored in individuals or groups. Grades should be 
recorded at least twice, at diagnosis and again at release from treatment30.
Few studies have compared the two systems of impairment 
assessment13,19,30, and no such studies have yet been conducted, in 
Northeastern Brazil, concerning disability evaluation using EHF-score 
versus WHO disability grading. Given the possible applicability of the 
EHF score as a tool for assessing impairment within leprosy programmes, 
several authors have pointed to the need for further studies evaluating its 
performance and validity6,19,30. This study sought to analyze the extent of 
impairment in leprosy patients based on the system of disability grading 
(DG) as well as the sum of the Eye-Hand-Foot impairment score (EHF 
score).
MATERIAL AND METHODS
Campina Grande is located in Paraíba State, Northeastern Brazil. In 
2005 it had an estimated population of 376,132 inhabitants11. In 2004 
145 new cases of leprosy26 were diagnosed. A cross-sectional study was 
carried out in a sample comprising 61 volunteers with leprosy who were 
invited to take part in the study.
The study was conducted from November 2003 to January 2005. 
The inclusion criteria were: residence in the municipality of Campina 
Grande-Paraíba State-Brazil, receiving public health-care assistance 
under the Brazilian Unified Health System (SUS), and taking MDT for 
active leprosy, irrespective of gender, clinical form or age. Six patients 
who presented any associated health problems whose sequelae could 
affect the peripheral nervous system or result in similar impairments 
to those of leprosy were excluded. Two subjects refused to participate.
Patients were examined at the health service or their homes. The 
impairments were measured using the DG - the tool standardized by 
the WHO38, and by the EHF score - Eye-Hand-Foot impairment score30.
To exclude inter-observer variation, all physical-functional 
assessments were conducted by a single experienced investigator 
(M.T.R.).
The data were analyzed using the Epi Info™ software version 3.3, 
with distribution of frequencies and averages, applying the Mann-
Whitney test with a significance level of 5%.
The project was approved by the Research Ethics Committee of the 
State University of Paraíba, under number 164/03. All participants, or 
their respective legal guardians, signed the informed written consent term.
RESULTS
We included 61 patients, 32 (52.5%) females and 29 (47.5%) males. 
The mean age was 41 years and median 43 years (range: 8-85 years).
Based on the working classification (leprosy group)38, 26 cases 
(42.6%) showed paucibacillary leprosy (PB) and 35 (57.4%) with 
multibacillary leprosy (MB).
A total of 25 (41%) leprosy patients showed impairments. Assessment 
of impairment using the DG scale, classified 36 of the subjects as DG 
0 (59%), 14 (23%) patients as DG 1 and 11 (18%) as DG 2. Among 
impairment patients, EHF scores ranged from 1 to 10 points (Table 1).
Table 2 shows a higher mean EHF score count in the DG 2 patient 
subgroup than the DG 1 patient subgroup. 
Of the patients classified as DG 1, 10 (71.4%) had up to two segments 
involved, whereas of those assigned DG 2, 8 (72.7%) had three or more 
impaired segments. 
Of the 25 patients with impairments, 13 (52%) had an EHF score of 
1 to 2 and impairments in up to two segments. Among those with EHF 
Table 1
Number of patients with impairment by WHO DG and EHF score (n = 25)
WHO disability grading
EHF Score
1 2 3 4 5 6 7 8 9 10 11 12 Total
Grade 1 2 8 2 2 – – – – – – – – 14
Grade 2 – 3 – – 3 2 1 1 – 1 – – 11
Total 2 11 2 2 3 2 1 1 – 1 – – 25
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scores greater than or equal to 3, nine (36%) had more than four affected 
segments (Table 3).
DISCUSSION
Given that both methods of measuring impairment combine 
impairments of different severities and sites into a single measure, they 
are concordant as severity increases, i.e. the greater the DG, the greater 
the EHF score. Consequently, the mean EHF total score in the DG 2 
patient subgroup was greater than in the DG 1 patient subgroup. Similar 
to data from MEIMA et al.19, all patients with EHF scores greater than 
or equal to five were found to have involvement of at least one extremity 
or eye with DG 2. 
The overlapping of impairments in the same individual, although 
occurring in both methods, seemed more evident in the scale of the EHF 
score. In the present study, while the DG predominantly classified patients 
with impairments in up to four segments as DG 1, the EHF score for the 
same group ranged from 1 to 8. Similarly, the DG classified patients with 
one to six impaired segments as grade 2, where the same group scored 
between 3 and 10 points on the EHF scale.
This is the case because the EHF score accounts for alteration in 
different areas and therefore provides more in-depth information on 
the degree of impairments in a given individual, a finding previously 
reported in an earlier study7.
The greater detail offered by the EHF score makes it more suited 
for assessing development of impairments over the course of treatment. 
Moreover, previous studies have pointed to higher sensitivity of the EHF 
score for registering changes in impairment than the maximum WHO 
disability grade6,7,30.
A limitation attributed to the EHF score is that a change in impairment 
can be “masked” if variations in grades assigned to different components 
occur in opposite directions, thereby canceling each other out while 
leaving total score unchanged28,30. However, this phenomenon may also 
occur when using the maximum WHO disability grade30. In a cohort 
study following 433 patients during treatment, the masking effect on 
EHF scores was a rare occurrence19.
A study investigating inter-observer reliability showed the EHF score 
to be slightly better than the DG20. Nevertheless, in light of the similar 
reliability of both methods, the author advocated the use of the DG by 
virtue of its simplicity and ease of application. 
However, the EHF score is merely the sum of the highest grades of 
impairment in each segment, and therefore the clinical methodology 
of assessing impairments is the same under both methods, the only 
difference being in the way impairments are classified. The simplicity of 
the 3-level DG scale is, though, more favorable as it enables simplifying 
records and monitoring systems. Nonetheless, from a clinical standpoint 
and for the purposes of monitoring patient conditions over the long 
term, the total sum of impairments of the EHF conveys more precise 
information than the conventional DG12,30.
This study presents some limitations related to the number of 
participants and individuals with impairments by leprosy. Therefore, 
the findings cannot be generalized. Despite these limitations, this study 
revealed that the elevated prevalence of impairment is in agreement 
with some data in the leprosy literature8,21,25,27. These findings suggest 
a delay in the diagnosis as an indicator of the operational difficulties 
of the programme23,28,33,36; highlight the need for monitoring of these 
subjects after treatment completion; organizing and developing 
activities related to the leprosy control activities carried out by Primary 
Health Care Services
CONCLUSIONS
The EHF score ranged from 1 to 10 points in the patient group with 
impairments, giving a mean score of 3.6 and median of 2 points. The 
majority of individuals presenting impairments were affected in at least 
Table 3
Number of affected sites in cases with impairments by DG and EHF score (n = 25).
Sites (n) WHO DG EHF Score
1 2 Total 1 2 3 4 5 6 7 8 9 10 11 12 Total
1 Site. 2 3 5 2 3 – – – – – – – – – – 5
2 Sites. 8 – 8 – 8 – – – – – – – – – – 8
3 Sites. 2 1 3 – – 2 – 1 – – – – – – – 3
4 Sites. 2 4 6 – – – 2 2 1 – 1 – – – – 6
5 Sites. – 2 2 – – – – – 1 1 – – – – – 2
6 Sites. – 1 1 – – – – – – – – – 1 – – 1
Total 14 11 25 2 11 2 2 3 2 1 1 – 1 – – 25
Table 2
Mean (SD), median EHF score by IG 1 and IG 2 subgroups.
WHO disability 
grading
EHF Score
Mean and Standard Deviation Median
DG 1 (n = 14) 2.28 ± 0.91 2*
DG 2 (n = 11) 5.27 ± 2.57 5
Total (n = 25) 3.6 ± 2.34 2
* Mann-Whitney, U: 9.227, p = 0.0024
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two sites. EHF score showed overlapping impairments in the segments 
examined and proved more suited than the DG classification system for 
describing the degree of physical impairment of patients.
Our findings corroborate the use of the EHF score for follow-up 
of patients with impairments, and suggest that the term “Escore OMP 
- Escore Olhos, Mãos e Pés” (Eye-hand-foot Score) should be adopted 
by the Leprosy Control Programme in Brazil.
RESUMO
Avaliação de incapacidades físicas em pessoas com hanseníase: 
comparação entre o grau de incapacidade e o Eye-Hand-Foot 
Score
Este estudo transversal avaliou a extensão das incapacidades físicas 
em 61 pessoas com hanseníase, em uso de poliquimioterapia (PQT), 
assistidos pelo Sistema Único de Saúde do Brasil, residentes em Campina 
Grande, Paraíba, Brasil. As incapacidades foram avaliadas por meio do 
grau de incapacidade (GI) preconizado pela OMS e pelo cálculo da soma 
das incapacidades – Eye-Hand-Foot impairment score (EHF score); 
incapacidades foram diagnosticadas em 41% dos sujeitos. Os GI 1 e 
2 foram atribuídos, respectivamente, para 23% e 18% deles. No grupo 
de pacientes com incapacidades físicas o EHF score variou de 1 a 10 
pontos e exibiu a média igual a 3,6 pontos. A maioria das pessoas com 
incapacidades possuía, pelo menos, duas partes do corpo afetadas. O EHF 
score evidenciou sobreposição de comprometimentos nos segmentos 
examinados e se mostrou mais apropriado que o sistema de classificação 
do GI para descrever a extensão das incapacidades físicas dos pacientes.
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